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Dear Sir,
The recent paper of Fltickiger et al. [1] on evaluation of fructosamine test is remarkable for its report of enormous intraindividual variations of total serum protein concentration and fructosamine value in Type I (insulin-dependent) diabetic individuals. Hrlzel [2] found a total (biological plus analytical) intraindividual variation in serum protein of 4.6% in Type 1 diabetic females (males 3.8%), whereas the variations reported by Fltickiger are up to six-(and possibly eight-) fold this magnitude. Moreover, we have observed an intraindividual variation of fructosamine concentration of 3.7% within a single day in Type I diabetic patients [3] , which is in keeping with H61zel's estimate of protein variation.
To reconcile the data of Flfickiger et al. with those of Hrlzel and ourselves, we are forced to postulate an additional source of variation in Fliickiger's information. One possible source is specimen collection and handling, with varying degrees of contamination introduced by residual fluid from the indwelling catheters, and incomplete mixing of frozen specimens. We, and no doubt your readership, would be interested to learn how Fltickiger et al. were able to exclude such errors as sources of variation. 
Combined response from the authors
Dear Sir, Johnson and Baker consider the variation of fructosamine and protein concentrations measured in our evaluation of the fructosamine assay enormous in comparison to that seen in their hands. They suggest problems in specimen collection and handling as explanation for the discrepancy. Drexel et al. are under the impression that under strictly standardised conditions intraindividual variability does not exceed analytical variability. We are going to demonstrate 973 that variability associated with performance of the fructosamine test is comparable in all laboratories.
The coefficient of variation of 3.7% cited by Johnson and Baker [1] is the median of median values ranging from 2.1-6.8% (n = 14). In Type 2 (non-insulin-dependent) diabetic patients (n = 14) the upper range even reached 8.2%. Considering the magnitude of these ranges our coefficients of variation (SD/mean • FE100) of 9.4 and 12.7% are roughly comparable. By inference, fluctuations of protein concentrations similar to those seen in our study must have been encountered by Johnson & Baker. Such ranges are not in conflict with intraindividual variability reported by Hrlzel [2] . In the latter investigation variability of analyses in blood drawn in the postbreakfast state once a week over 8 weeks are reported and not on samples drawn at different times during the same day.
Drexel et al., in their study of nondiabetic pregnant women, show that under the strictly controlled conditions of a glucose tolerance test fructosamine values deviate from the mean value by+ 0-13%. This value by far exceeds analytical variability which in our hands was 2-3%. At an average fructosamine concentration of 1.68 mmol/1 their range of values is 0-0.44 mmol/1, identical to our range for this subgroup.
Furthermore, in a recently published study serum fructosamine determinations were performed in control subjects on postbreakfast blood specimen obtained at regular intervals over 5 weeks. Ranges from 0.15 to 0.9 mmol/1 were observed [3] . This range of values in comparable to that reported by us within a single day.
The uncertainty of a fructosamine determination of up to 1 mmol/1 is therefore well documented in both diabetic and control subjects. In view of the skewed distribution of variability towards lower values [1, 3] , the uncertainty of a fructosamine determination is probably closer to 0.5 mmol/1 which can lead to misjudgment of the averaged blood glucose concentration by 4 mmol/1. Such uncertainty arising in part from variations in protein concentration and probably also from non-specificity of the test [4] can somewhat be reduced by correction for the protein concentration.
Yours sincerely, R. Fliickiger, T. Woodtli and W. Berger.
